Breaking News Instant updates and real-time market news.

SRDX

Surmodics

$64.72

-0.32 (-0.49%)

18:18
11/06/18
11/06
18:18
11/06/18
18:18

Surmodics' SurVeil study says data met primary endpoint and secondary endpoints

Surmodics announced that data from the PREVEIL early feasibility study of the company's SurVeil drug-coated balloon was shared in a late-breaking clinical trial presentation at the Vascular Interventional Advances 2018 conference in Las Vegas. PREVEIL is a prospective, U.S., multi-center, single-arm trial designed to assess the safety and feasibility of the SurVeil DCB in the treatment of subjects with symptomatic peripheral artery disease due to de novo lesions of the femoral and popliteal arteries. Twelve-month data from the study show that acute success measures of safety were achieved in 100 percent of subjects. No subjects required re-intervention of either the target lesion or the target vessel at 12 months. The results also demonstrate continued significant improvement in Rutherford classification, resting ankle brachial index, and walking impairment questionnaire including walking distance, walking speed and stair-climbing scores at 12 months. As was presented with the six-month results, median paclitaxel plasma concentration peaked immediately post-procedure and was undetectable at 30 days. Secondary technical, device, and procedure success criteria were achieved. The SurVeil DCB is not yet approved for sale in the United States.

  • 09

    Nov

SRDX Surmodics
$64.72

-0.32 (-0.49%)

08/06/18
LSCM
08/06/18
NO CHANGE
Target $90
LSCM
Buy
Surmodics price target raised to $90 from $76 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for Surmodics to $90 citing the company's "solid" Q3 results and raised guidance for fiscal 2018. The analyst says that while core businesses are gems, he's most excited about the future opportunities for Surmodics. The company is "clearly making progress" on at least 15 510 (k) products to launch over the next several years, O'Neil tells investors in a research note. He affirms a Buy rating on the shares.
08/07/18
NEED
08/07/18
NO CHANGE
Target $74
NEED
Buy
Surmodics price target raised to $74 from $55 at Needham
Needham analyst Mike Matson raised his price target on Surmodics (SRDX) to $74 and kept his Buy rating after its Q3 earnings beat and raised FY18 outlook. The analyst anticipates accelerating revenue growth with more upside to consensus estimates coming from the company's new products such as the .014'' and .018" balloon dilation catheters and Telemark microcatheter, along with its deferred revenue associated with the Abbott (ABT) agreement milestones.
08/07/18
BRRR
08/07/18
NO CHANGE
Target $73
BRRR
Outperform
Surmodics price target raised to $73 from $43 at Barrington
Barrington analyst Michael Petusky raised his price target for Surmodics to $73 citing the company's beat in Q3 and its progress on SurVeil DCB and 510(k) products. The analyst's sum-of-the-parts methodology assigns $38 per share for the core business, $22.75 for the SurVeil DCB program with Abbott (ABT), $7.50 for the 510(k) products program, and $4.75 per share for the net cash on the balance sheet. He keeps an Outperform rating on Surmodics.
08/23/18
BRRR
08/23/18
NO CHANGE
Target $77
BRRR
Outperform
Surmodics price target raised to $77 from $73 at Barrington
Barrington analyst Michael Petusky raised his price target for Surmodics to $77 after traveling with management. Despite the recent rally in the shares, the analyst believes the Surmodics story "remains in the relatively early innings." He keeps an Outperform rating on the name.

TODAY'S FREE FLY STORIES

ETRN

Equitrans Midstream

$20.87

-1.12 (-5.09%)

06:42
11/19/18
11/19
06:42
11/19/18
06:42
Initiation
Equitrans Midstream initiated  »

Equitrans Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOG

Extraction Oil & Gas

$6.74

-0.25 (-3.58%)

06:42
11/19/18
11/19
06:42
11/19/18
06:42
Hot Stocks
Extraction Oil & Gas announces $100M stock repurchase program »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPB

Spectrum Brands

$59.36

0.87 (1.49%)

, ENR

Energizer

$49.91

-1.53 (-2.97%)

06:41
11/19/18
11/19
06:41
11/19/18
06:41
Hot Stocks
Spectrum Brands' Auto Business Sale agreement contains 'go-shop' provision »

The Auto Business Sale…

SPB

Spectrum Brands

$59.36

0.87 (1.49%)

ENR

Energizer

$49.91

-1.53 (-2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

DAR

Darling Ingredients

$20.06

-0.24 (-1.18%)

06:40
11/19/18
11/19
06:40
11/19/18
06:40
Upgrade
Darling Ingredients rating change  »

JPMorgan sees earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

, GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

06:40
11/19/18
11/19
06:40
11/19/18
06:40
Periodicals
Google, Temasek see $240B Southeast Asia internet economy by 2025, Reuters says »

Southeast Asia's…

GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

CFX

Colfax

$28.00

0.31 (1.12%)

, BX

Blackstone

$32.48

-0.02 (-0.06%)

06:39
11/19/18
11/19
06:39
11/19/18
06:39
Hot Stocks
Colfax to acquire DJO Global for $3.15B in cash »

Colfax (CFX) announced it…

CFX

Colfax

$28.00

0.31 (1.12%)

BX

Blackstone

$32.48

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

XEC

Cimarex Energy

$88.63

-0.27 (-0.30%)

, REN

Resolute Energy

$30.51

0.67 (2.25%)

06:38
11/19/18
11/19
06:38
11/19/18
06:38
Hot Stocks
Cimarex Energy to acquire Resolute Energy for $35 per share »

Cimarex Energy (XEC) and…

XEC

Cimarex Energy

$88.63

-0.27 (-0.30%)

REN

Resolute Energy

$30.51

0.67 (2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$8.91

-0.1 (-1.11%)

, SPOT

Spotify

$134.14

-2.91 (-2.12%)

06:37
11/19/18
11/19
06:37
11/19/18
06:37
Periodicals
Pandora, Spotify turn to podcasts for listeners, profit, WSJ reports »

Spotify (SPOT) and…

P

Pandora

$8.91

-0.1 (-1.11%)

SPOT

Spotify

$134.14

-2.91 (-2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$28.00

0.31 (1.12%)

06:37
11/19/18
11/19
06:37
11/19/18
06:37
Hot Stocks
Breaking Hot Stocks news story on Colfax »

Colfax to acquire DJO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FQVLF

First Quantum Minerals

$0.00

(0.00%)

06:37
11/19/18
11/19
06:37
11/19/18
06:37
Upgrade
First Quantum Minerals rating change  »

First Quantum Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STNE

StoneCo

$25.31

0.69 (2.80%)

06:36
11/19/18
11/19
06:36
11/19/18
06:36
Initiation
StoneCo initiated  »

StoneCo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

SAVE

Spirit Airlines

$52.43

-0.54 (-1.02%)

06:33
11/19/18
11/19
06:33
11/19/18
06:33
Initiation
Spirit Airlines initiated  »

Spirit Airlines initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

XEC

Cimarex Energy

$88.63

-0.27 (-0.30%)

, REN

Resolute Energy

$30.51

0.67 (2.25%)

06:32
11/19/18
11/19
06:32
11/19/18
06:32
Hot Stocks
Breaking Hot Stocks news story on Cimarex Energy, Resolute Energy »

Cimarex to acquire…

XEC

Cimarex Energy

$88.63

-0.27 (-0.30%)

REN

Resolute Energy

$30.51

0.67 (2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPB

Spectrum Brands

$59.36

0.87 (1.49%)

06:32
11/19/18
11/19
06:32
11/19/18
06:32
Hot Stocks
Spectrum Brands sees FY19 adjusted EBITDA $560M-$580M »

Spectrum Brands expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LUV

Southwest

$52.59

-0.64 (-1.20%)

06:31
11/19/18
11/19
06:31
11/19/18
06:31
Initiation
Southwest initiated  »

Southwest initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$29.61

0.05 (0.17%)

06:31
11/19/18
11/19
06:31
11/19/18
06:31
Conference/Events
Aimmune to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 27

    Nov

  • 12

    Dec

SPB

Spectrum Brands

$59.36

0.87 (1.49%)

06:30
11/19/18
11/19
06:30
11/19/18
06:30
Earnings
Spectrum Brands reports Q4 adjusted EPS 79c, consensus $1.08 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AAL

American Airlines

$36.74

-1.08 (-2.86%)

06:30
11/19/18
11/19
06:30
11/19/18
06:30
Initiation
American Airlines initiated  »

American Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

06:30
11/19/18
11/19
06:30
11/19/18
06:30
Hot Stocks
Innovus Pharmaceuticals acquires rights to four products from Boston Topicals »

Innovus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$139.55

-4.31 (-3.00%)

06:29
11/19/18
11/19
06:29
11/19/18
06:29
Periodicals
Zuckerberg adopts more aggressive approach as Facebook is at 'war', WSJ reports »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

JBLU

JetBlue

$18.03

-0.14 (-0.77%)

06:29
11/19/18
11/19
06:29
11/19/18
06:29
Initiation
JetBlue initiated  »

JetBlue initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$92.30

0.34 (0.37%)

06:26
11/19/18
11/19
06:26
11/19/18
06:26
Initiation
United Continental initiated  »

United Continental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

DAL

Delta Air Lines

$55.88

-0.21 (-0.37%)

06:25
11/19/18
11/19
06:25
11/19/18
06:25
Initiation
Delta Air Lines initiated  »

Delta Air Lines initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$67.68

0.29 (0.43%)

06:23
11/19/18
11/19
06:23
11/19/18
06:23
Initiation
Alaska Air initiated  »

Alaska Air initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$8.04

-0.135 (-1.65%)

, SIEGY

Siemens

$0.00

(0.00%)

06:21
11/19/18
11/19
06:21
11/19/18
06:21
Periodicals
GE chases power sales in Iraq as report highlights corruption concerns, WSJ says »

General Electric (GE) has…

GE

General Electric

$8.04

-0.135 (-1.65%)

SIEGY

Siemens

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.